Talphera Inc. Common Stock (TLPH)

About TLPH

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

12

Website

talphera.com

Fundamentals

1-day range

$1.19$1.28

Market cap

$69.03M

P/E (trailing)

—

P/E (forward)

-5.02

EPS (trailing)

$-0.23

Dividend yield

—

Beta

0.70

Avg. volume

312.6K

Forecasts

3 analyst ratings

Talphera Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• TLPH

  Talphera Inc. Common Stock

  $1.2

  ▼ 2.44%
  Market cap $69.03MP/E —
  $0.4$1.57
• XBIT

  XBiotech Inc. Common Stock

  $2.27

  ▼ 0.00%
  Market cap $69.51MP/E —
  $2.09$3.59
• FRMM

  Forum Markets Incorporated Common Stock

  $5.9

  ▲ 4.24%
  Market cap $70.30MP/E —
  $1.76$31
• IBIO

  iBio Inc. Common Stock

  $1.36

  ▼ 2.86%
  Market cap $70.54MP/E —
  $0.7708$3.82
• OSTX

  OS Therapies Incorporated Common Stock

  $1.64

  ▼ 2.38%
  Market cap $70.58MP/E —
  $1.15$2.54
• ACRV

  Acrivon Therapeutics Inc. Common Stock

  $2.06

  ▼ 4.19%
  Market cap $66.77MP/E —
  $1.27$3.56
• SPRO

  Spero Therapeutics Inc. Common Stock

  $1.2

  ▼ 0.83%
  Market cap $66.59MP/E 4.73
  $1.08$3.08

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Talphera, Inc. (TLPH) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/13/2026
• Talphera Q2 EPS $(0.06) Beats $(0.07) Estimate
  Benzinga · 8/12/2026
• Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026
  Yahoo · 8/5/2026

• Abhinav Jain · June 22, 2026 · Grant

  30.7K
• Abhinav Jain · June 22, 2026 · Grant

  5.1K
• Marina Bozilenko · June 22, 2026 · Grant

  30.7K
• Marina Bozilenko · June 22, 2026 · Grant

  5.1K
• Joseph Todisco · June 22, 2026 · Grant

  30.7K
• Joseph Todisco · June 22, 2026 · Grant

  5.1K
• Jill Marie Broadfoot · June 22, 2026 · Grant

  30.7K
• Jill Marie Broadfoot · June 22, 2026 · Grant

  5.1K
• Adrian Adams · June 22, 2026 · Grant

  30.7K
• Adrian Adams · June 22, 2026 · Grant

  5.1K
• Mark A. Wan · June 22, 2026 · Grant

  30.7K
• Mark A. Wan · June 22, 2026 · Grant

  5.1K
• Stephen J. Hoffman · June 22, 2026 · Grant

  30.7K
• Stephen J. Hoffman · June 22, 2026 · Grant

  5.1K
• Shakil Aslam · May 20, 2026 · Tax Withholding

  4.5K @ $0.824

Institutional Ownership

March 31, 2026

Total shares held

21.85M

Total value held

$16.24M

Institutional holders

44